Sujith K. Joseph, PhD
- Cancer and Blood Disorders
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Office locations:
1102 Bates Avenue
Houston, TX 77030
Get to know Sujith K. Joseph, PhD
Education
| School | Education | Degree | Year |
|---|---|---|---|
| National Institutes of Health | Post-doctoral Fellowship | Immunology and Vaccinology | 2015 |
| University of Illinois College of Medicine at Rockford | Post-doctoral Fellowship | Postdoctoral Fellowship, Immunology and Vaccinology | 2012 |
| Chhatrapati Shahu Ji Maharaj University | PhD | Doctor of Philosophy, Life Sciences - Immunology and Vaccinology | 2011 |
| Mahatma Gandhi University, India | Masters | Master of Science, Zoology | 2003 |
Awards
2021 Team Science Award, American Academy of Cancer Research (AACR)
2004 Rank-Certificate of Merit in Master’s program, Mahatma Gandhi University, India
2001-2003 Merit Scholarship for academic excellence in Master’s Program
1998-2001 Merit Scholarship for academic excellence in Bachelors Program
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Research Area:
Immunotherapy
Sujith K. Joseph, PhD, is a scientist trained in human immunology of prophylactic and therapeutic interventions. With a doctorate focused on understanding immune modulation on human and animal systems, Dr. Joseph continued his research at the University of Illinois (UIC) and the National Institutes of Health (NIH) to identify and optimize vaccine candidates against infectious diseases, based on naturally occurring protective immune responses in endemic populations. The combination of the scientific environment and mentoring he received at these institutions helped him gather the skills, knowledge and ingenuity necessary to further extend his expertise to interrogations in tumor immunotherapy.
Currently, he conducts translational research with gene-modified T-cells for solid tumors in children and young adults within the Center for Cell and Gene Therapy at Baylor College of Medicine. His research focuses on the pre-clinical development of novel Chimeric Antigen Receptor (CAR) molecules and delineating immune responses in patients undergoing CAR T-cell therapy in clinical trials.
